• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Al-Botaty, B., El-Khoely, A., Elsayed, E., Eissa, A. (2022). Insight into the Pathophysiology of Myocardial Infarction. Journal of Advanced Pharmacy Research, 6(4), 223-237. doi: 10.21608/aprh.2022.155725.1188
Basant Al-Botaty; Abeer El-Khoely; Elsayed Kamal Elsayed; Amany Eissa. "Insight into the Pathophysiology of Myocardial Infarction". Journal of Advanced Pharmacy Research, 6, 4, 2022, 223-237. doi: 10.21608/aprh.2022.155725.1188
Al-Botaty, B., El-Khoely, A., Elsayed, E., Eissa, A. (2022). 'Insight into the Pathophysiology of Myocardial Infarction', Journal of Advanced Pharmacy Research, 6(4), pp. 223-237. doi: 10.21608/aprh.2022.155725.1188
Al-Botaty, B., El-Khoely, A., Elsayed, E., Eissa, A. Insight into the Pathophysiology of Myocardial Infarction. Journal of Advanced Pharmacy Research, 2022; 6(4): 223-237. doi: 10.21608/aprh.2022.155725.1188

Insight into the Pathophysiology of Myocardial Infarction

Article 5, Volume 6, Issue 4, October 2022, Page 223-237  XML PDF (492.92 K)
Document Type: Review Article
DOI: 10.21608/aprh.2022.155725.1188
View on SCiNiTO View on SCiNiTO
Authors
Basant Al-Botatyorcid ; Abeer El-Khoelyorcid ; Elsayed Kamal Elsayed email orcid ; Amany Eissaorcid
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo,11795, Egypt
Abstract
Myocardial infarction is classified as the irreversible myocardial cell death following ischemia. Ischemia could be initiated as a result of atherosclerotic or variable non-atherosclerotic causes. Consequent effects of ischemia are primarily caused due to oxidative stress which is the main precursor of cell death. Myocardial cell death is triggered through intrinsic or extrinsic pathways. In both pathways, apoptosis has been clearly explained through different studies but recently, necroptosis was determined to be involved. The heart has negligible ability for regeneration, thus infarcted regions are healed by replacing dead cells with scar formation. Infarct healing is triggered through an inflammatory cascade, induced by alarmins released from dying cells. Clearance of dead cells by immune cells is followed with the activation of fibroblasts to promote deposition of extracellular matrix proteins. This review discusses the events involved following ischemia including the mechanistic signalling during injury, inflammation, and repair of the infarcted heart. Moreover, the possible complications are mentioned along with the established treatment strategies and some new therapeutic approaches for myocardial infarction.
Keywords
Apoptosis; Inflammatory response; Ischemia; Myocardial infarction; Necroptosis
Main Subjects
Section D: Clinical Pharmacy & Pharmacology
Statistics
Article View: 1,510
PDF Download: 1,406
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.